Lv4
420 积分 2024-03-26 加入
Pharmacodynamic Biomarkers of Mosunetuzumab Efficacy and Safety in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma: Results from a Phase I/II Study
1天前
已完结
Pharmacodynamic Biomarkers of Mosunetuzumab Efficacy and Safety in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma: Results from a Phase I/II Study
1天前
已关闭
Defining immune reset: achieving sustained remission in autoimmune diseases
3天前
已完结
RG6234, a GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, Is Highly Active in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Intravenous (IV) and First Subcutaneous (SC) Results from a Phase I Dose-Escalation Study
4天前
已完结
RG6234, a GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, Is Highly Active in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Intravenous (IV) and First Subcutaneous (SC) Results from a Phase I Dose-Escalation Study
4天前
已关闭
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
21天前
已完结
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
24天前
已完结
Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans
1个月前
已完结
UGT2B17及UGT2B4基因多态性与胰腺癌易感性的关联研究
1个月前
已完结
Increasing Lipolysis and Reducing Atherosclerosis
11个月前
已采纳
高氯高氨废水 化学需氧量的测定 氯离子校正法
11个月前
已采纳
皖公网安备34019202002308
